Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 32.59% vs 32.48% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 62.02% vs -28.34% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 3.17% vs 37.69% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 207.53% vs 21.67% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Astrazeneca Phar With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
2,275.58
3,391.85
-1,116.27
-32.91%
Other Operating Income
0.00
82.11
-82.11
-100.00%
Total Operating income
2,275.58
3,473.96
-1,198.38
-34.50%
Raw Material Cost
9.49
1,505.27
-1,495.78
-99.37%
Purchase of Finished goods
1,859.42
0.00
1,859.42
(Increase) / Decrease In Stocks
-488.37
7.68
-496.05
-6,458.98%
Employee Cost
264.38
423.13
-158.75
-37.52%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
116.00
0.00
116.00
Other Expenses
252.63
813.80
-561.17
-68.96%
Total Expenditure (Excl Depreciation)
2,013.55
2,749.88
-736.33
-26.78%
Operating Profit (PBDIT) excl Other Income
262.03
724.08
-462.05
-63.81%
Other Income
28.49
49.80
-21.31
-42.79%
Operating Profit (PBDIT)
290.52
773.88
-483.36
-62.46%
Interest
4.49
61.44
-56.95
-92.69%
Exceptional Items
-5.25
-12.16
6.91
56.83%
Gross Profit (PBDT)
280.78
700.28
-419.50
-59.90%
Depreciation
28.58
164.47
-135.89
-82.62%
Profit Before Tax
252.20
535.81
-283.61
-52.93%
Tax
64.68
135.15
-70.47
-52.14%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
187.52
400.67
-213.15
-53.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
187.52
400.67
-213.15
-53.20%
Equity Capital
5.00
24.78
-19.78
-79.82%
Face Value
2.00
1.00
0.00
Reserves
867.79
4,374.34
-3,506.55
-80.16%
Earnings per share (EPS)
75.01
16.17
58.84
363.88%
Diluted Earnings per share
75.01
16.47
58.54
355.43%
Operating Profit Margin (Excl OI)
11.51%
21.35%
0.00
-9.84%
Gross Profit Margin
12.34%
20.65%
0.00
-8.31%
PAT Margin
8.24%
11.81%
0.00
-3.57%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,275.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 32.59% vs 32.48% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 187.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 62.02% vs -28.34% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 262.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 3.17% vs 37.69% in Mar 2025
Annual - Interest
Interest 4.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 207.53% vs 21.67% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.51%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
